2023
DOI: 10.3390/uro3020012
|View full text |Cite
|
Sign up to set email alerts
|

Prostate Cancer: Advances in Genetic Testing and Clinical Implications

Abstract: The demand for genetic testing (GT) for prostate cancer (PCa) is expanding, but there is limited knowledge about the genetic counseling (GC) needs of men. A strong-to-moderate inherited genetic predisposition causes approximately 5–20% of prostate cancer (PCa). In men with prostate cancer, germline testing may benefit the patient by informing treatment options, and if a mutation is noticed, it may also guide screening for other cancers and have family implications for cascade genetic testing (testing of close … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 97 publications
0
0
0
Order By: Relevance
“…Localized on chromosome 17, Homeobox B13 (HOXB13) is a homeobox transcription factor with mutations being reported in 0.7% to 1.4% of PCa cases [216]. The homeobox genes encode for nuclear proteins and possess the main function of being transcription factors.…”
Section: Homeobox B13mentioning
confidence: 99%
“…Localized on chromosome 17, Homeobox B13 (HOXB13) is a homeobox transcription factor with mutations being reported in 0.7% to 1.4% of PCa cases [216]. The homeobox genes encode for nuclear proteins and possess the main function of being transcription factors.…”
Section: Homeobox B13mentioning
confidence: 99%